Suche einschränken:
Zur Kasse

15 Ergebnisse.

Implications of Genomics for Public Health: Workshop Summary

Institute Of Medicine / Board on Health Promotion and Disease Pr / Committee on Genomics and the Public's H
Implications of Genomics for Public Health: Workshop Summary
Genomics is the study of the entire human genome. Genomics explores not only the actions of single genes, but also the interactions of multiple genes with each other and with the environment. As a result, genomics has great potential for improving the health of the public. However, realizing the benefits of genomics requires a systematic evaluation of its potential contributions and an understanding of the information necessary to facilitate t...

CHF 40.90

Veterans and Agent Orange: Length of Presumptive Period f...

Institute Of Medicine / Board on Health Promotion and Disease Pr / Committee to Review the Health Effects i
Veterans and Agent Orange: Length of Presumptive Period for Association Between Exposure and Respiratory Cancer
From 1962 to 1971, US military forces sprayed herbicides over Vietnam to strip the thick jungle canopy that helped conceal opposition forces, to destroy crops that enemy forces might depend on, and to clear tall grasses and bushes from the perimeters of US base camps and outlying fire-support bases. Mixtures of 2, 4-dichlorophenoxyacetic acid (2, 4-D), 2, 4, 5-trichlorophenoxyacetic acid (2, 4, 5-T), picloram, and cacodylic acid made up the ma...

CHF 40.90

Measuring What Matters: Allocation, Planning, and Quality...

Institute Of Medicine / Board on Health Promotion and Disease Pr / Committee on the Ryan White Care Act Dat
Measuring What Matters: Allocation, Planning, and Quality Assessment for the Ryan White Care ACT
The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act gives funding to cities, states, and other public and private entities to provide care and support services to individuals with HIV and AIDS who have low-incomes and little or no insurance. The CARE Act is a discretionary program that relies on annual appropriations from Congress to provide care for low-income, uninsured, or underinsured individuals who have no other resources to...

CHF 77.00

Immunization Safety Review: Vaccinations and Sudden Unexp...

Institute Of Medicine / Board on Health Promotion and Disease Pr / Immunization Safety Review Committee
Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy
With current recommendations calling for infants to receive multiple doses of vaccines during their first year of life and with sudden infant death syndrome (SIDS) the most frequent cause of death during the postneonatal period, it is important to respond to concerns that vaccination might play a role in sudden unexpected infant death. The committee reviewed epidemiologic evidence focusing on three outcomes: SIDS, all SUDI (sudden unexpected d...

CHF 52.90

Scientific and Policy Considerations in Developing Smallp...

Institute Of Medicine / Board on Health Promotion and Disease Pr
Scientific and Policy Considerations in Developing Smallpox Vaccination Options: A Workshop Report
At the World Health Assembly in May 1980, the World Health Organization declared the world free of smallpox. Smallpox vaccination of civilians is now indicated only for laboratory workers directly involved with smallpox or closely related orthopox viruses. However recent questions raised by the terrorist attacks in fall 2001 have renewed concerns about possible outbreaks of smallpox resulting from its use as a biological weapon. In June 2002, ...

CHF 40.90

Immunization Safety Review: Sv40 Contamination of Polio V...

Institute Of Medicine / Board on Health Promotion and Disease Pr / Immunization Safety Review Committee
Immunization Safety Review: Sv40 Contamination of Polio Vaccine and Cancer
The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the evidence on possible causal associations between immunizations and certain adverse outcomes, and to then present conclusions and recommendations. The committee's mandate also includes assessing the broader societal significance of these immunization safety issues. While all the committee members share the view that immunization is genera...

CHF 51.90

Characterizing Exposure of Veterans to Agent Orange and O...

Institute Of Medicine / Board on Health Promotion and Disease Pr / Committee on the Assessment of Wartime E
Characterizing Exposure of Veterans to Agent Orange and Other Herbicides Used in Vietnam: Interim Findings and Recommendations
From 1962 to 1971, US military forces sprayed more than 19 million gallons of herbicides over Vietnam to strip the thick jungle canopy that helped conceal opposition forces, to destroy crops that enemy forces might depend on, and to clear tall grass and bushes from around the perimeters of US base camps and outlying fire-support bases. Most large-scale spraying operations were conducted from airplanes and helicopters, but herbicides were also ...

CHF 64.00

Vaccine Safety Forum: Summaries of Two Workshops

Institute Of Medicine / Board on Health Promotion and Disease Pr
Vaccine Safety Forum: Summaries of Two Workshops
On November 6, 1995, the Institute of Medicine's Vaccine Safety Forum convened a workshop on detecting and responding to adverse events following vaccination. Workshop speakers and participants discussed the difficulties in detecting adverse events, current adverse events detection and response methods and procedures, suggestions for improving the means of detecting and responding to adverse events following vaccination, and future areas of re...

CHF 64.00

New Vaccine Development: Establishing Priorities: Volume ...

Institute Of Medicine / Board On Population Health And Public He / Division Of Health Promotion And Disease
New Vaccine Development: Establishing Priorities: Volume II, Diseases of Importance in Developing Countries
Common diseases cost the developing world an enormous amount in terms of human life, health, and productivity, as well as lost economic potential. New and effective vaccines could not only improve the quality of life for millions of residents in developing countries, they could also contribute substantially to further economic development. Using data from the World Health Organization and other international agencies, this book analyzes diseas...

CHF 84.00

Immunization Safety Review: Influenza Vaccines and Neurol...

Institute Of Medicine / Board on Health Promotion and Disease Pr / Immunization Safety Review Committee
Immunization Safety Review: Influenza Vaccines and Neurological Complications
Infection with the influenza virus can have a serious effect on the health of people of all ages, although it is particularly worrisome for infants, the elderly, and people with underlying heart or lung problems. A vaccine exists (the "flu" shot) that can greatly decrease the impact of influenza. Because the strains of virus that are expected to cause serious illness and death are slightly different every year, the vaccine is also slightly dif...

CHF 79.00

Who Will Keep the Public Healthy?: Workshop Summary

Institute Of Medicine / Board on Health Promotion and Disease Pr / Committee on Educating Public Health Pro
Who Will Keep the Public Healthy?: Workshop Summary
In today's world the public faces many health threats from bioterrorism to the epidemic of obesity. It's thus important to have an effective public health system. This system depends significantly on the quality and preparedness of our public health workforce as well as the quality of public health education and training. In March, 2001 the Robert Wood Johnson Foundation asked the Institute of Medicine (IOM) to examine the education of public ...

CHF 64.00

Veterans and Agent Orange: Update 2002

Institute of Medicine / Board on Health Promotion and Disease Pr / Committee to Review the Health Effects i
Veterans and Agent Orange: Update 2002
The federal government operates six major health care programs that serve nearly 100 million Americans. Collectively, these programs significantly influence how health care is provided by the private sector. Leadership by Example explores how the federal government can leverage its unique position as regulator, purchaser, provider, and research sponsor to improve care--not only in these six programs but also throughout the nation's health care...

CHF 139.00